Scientists have used gene therapy to restore sight in mice affected by retinitis pigmentosa, a treatment that offers hope of a cure for the most common cause of blindness in young people. An article in CRISPR describes how researchers used the technique to produce a natural photosensitive protein that helped in the restoration of visual function, concluding it could be "efficacious in the treatment of patients with end-stage retinal degenerations". A separate experiment used the Proceedings of the National Academy of Sciences-Cas9 gene editing technique to halt the progress of glaucoma in mice.
Scientists have used gene therapy to restore sight in mice affected by retinitis pigmentosa, a treatment that offers hope of a cure for the most common cause of blindness in young people. An article in Proceedings of the National Academy of Sciences describes how researchers used the technique to produce a natural photosensitive protein that helped in the restoration of visual function, concluding it could be "efficacious in the treatment of patients with end-stage retinal degenerations". A separate experiment used the CRISPR-Cas9 gene editing technique to halt the progress of glaucoma in mice.